What is the most recent earnings date for AUTL stock?
AUTOLUS THERAPEUTICS PLC (AUTL) last reported earnings on 3/18/2026.
NASDAQ:AUTL • US05280R1005
Past quarterly earnings results for AUTOLUS THERAPEUTICS PLC (AUTL), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.30 | -0.23 | -30.31% | 3.23% | 21.144M | 21.737M | -2.73% | - |
| Q2 2025 | -0.18 | -0.24 | 25.13% | 18.18% | 20.923M | 13.163M | 58.95% | - |
| Q1 2025 | -0.26 | -0.26 | -1.96% | -8.33% | 8.982M | 2.106M | 326.50% | -10.99% |
| Q4 2024 | -0.10 | -0.21 | 52.34% | 77.78% | 29K | 3.039M | -99.05% | - |
| Q3 2024 | -0.31 | -0.22 | -41.83% | -19.23% | 131.753K | -100.00% | -100.00% | |
| Q2 2024 | -0.22 | -0.20 | -11.01% | 15.38% | 63.75K | -100.00% | - | |
| Q1 2024 | -0.24 | -0.06 | -327.81% | -4.35% | 10.091M | 25.5M | -60.43% | 681.04% |
| Q4 2023 | -0.45 | -0.26 | -74.72% | -95.65% | 365.568K | -100.00% | -100.00% | |
| Q3 2023 | -0.26 | -0.26 | -1.96% | 44.56% | 406K | 455.216K | -10.81% | -82.87% |
| Q2 2023 | -0.26 | -0.23 | -13.65% | 43.48% | 139.23K | -100.00% | - | |
| Q1 2023 | -0.23 | -0.27 | 15.31% | 43.90% | 1.292M | 360.193K | 258.70% | 660.00% |
| Q4 2022 | -0.23 | -0.27 | 16.10% | 54.90% | 3.83M | 3.262M | 17.41% | 2,027.78% |
| Q3 2022 | -0.47 | -0.47 | 1.00% | 0.21% | 2.37M | 137.7K | 1,621.13% | 887.50% |
| Q2 2022 | -0.46 | -0.43 | -7.38% | 2.13% | 245.371K | -100.00% | -100.00% | |
| Q1 2022 | -0.41 | -0.49 | 16.45% | 21.15% | 170K | 288.517K | -41.08% | -37.04% |
| Q4 2021 | -0.51 | -0.47 | -8.36% | 38.55% | 180K | 200.94K | -10.42% | -55.00% |
| Q3 2021 | -0.47 | -0.52 | 8.86% | 34.72% | 240K | 253.297K | -5.25% | -64.71% |
| Q2 2021 | -0.47 | -0.51 | 7.64% | 24.19% | 1.65M | 197.992K | 733.37% | 468.97% |
| Q1 2021 | -0.52 | -0.62 | 15.67% | 13.33% | 270K | 351.778K | -23.25% | -20.59% |
| Q4 2020 | -0.83 | -0.78 | -6.29% | - | 400K | 346.678K | 15.38% | - |
| Q3 2020 | -0.72 | -0.72 | 0.11% | - | 680K | 309.172K | 119.94% | - |
| Q2 2020 | -0.62 | -0.72 | 14.25% | - | 290K | 385.121K | -24.70% | - |
| Q1 2020 | -0.60 | -0.76 | 20.69% | - | 340K | 612K | -44.44% | - |
Notes
AUTOLUS THERAPEUTICS PLC (AUTL) last reported earnings on 3/18/2026.
AUTOLUS THERAPEUTICS PLC (AUTL) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, AUTOLUS THERAPEUTICS PLC (AUTL) has beaten EPS estimates in 2 out of 4 releases.